Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza

ClinicalTrials.gov ID: NCT00391768

Public ClinicalTrials.gov record NCT00391768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Oseltamivir (Tamiflu®) for the Treatment of Children Less Than 24 Months of Age With Confirmed Influenza Infection (CASG 114)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn how to treat influenza in children less than 2 years of age. Tamiflu®, the drug being studied, is approved for treatment of children 1 year of age and older with influenza. Researchers want to learn more about the activity of Tamiflu® in the body to determine a dose of that is safe, well-tolerated, and effective in young children with influenza. Children less than 24 months of age with confirmed influenza will receive Tamiflu® 2 times a day for 5 days. Older participants will be enrolled first and younger children will be enrolled after the safety data is reviewed for older participants. Study procedures include blood samples, swabs from inside the nose, and body and nervous system evaluations. Participants may be involved in study related procedures for up to 37 days.

Study identification

NCT ID
NCT00391768
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
87 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 23 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
Feb 28, 2010
Completion
Mar 31, 2010
Last update posted
Apr 30, 2013

2007 – 2010

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35117
Arkansas Children's Hospital - Infectious Diseases Little Rock Arkansas 72202-3500
Miller Children's Hospital Long Beach - Bickerstaff Family Center Long Beach California 90806-1701
Children's Hospital of Orange County Orange California 92868-3835
Rady Children's Hospital San Diego San Diego California 92123-4223
Children's Hospital Colorado - Infectious Disease Aurora Colorado 80045-7106
Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease Washington D.C. District of Columbia 20010-2916
University of Florida - Shands Children's Hospital Gainesville Florida 32610-0296
University of South Florida - Tampa General Hospital - Pediatrics Tampa Florida 33606-3438
Emory Children's Center - Pediatric Infectious Diseases Atlanta Georgia 30322-1014
Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases Atlanta Georgia 30322
Louisiana State University Health Shreveport - Pediatrics Shreveport Louisiana 71103-4228
University of Mississippi - Children's Infectious Diseases Jackson Mississippi 39216-4505
Washington University School of Medicine in St. Louis - Center for Clinical Studies St Louis Missouri 63110-1010
University of Nebraska Medical Center - Children's Hospital and Medical Center - Infectious Diseases Omaha Nebraska 68114-4108
Cohen Children's Medical Center - Pediatric Infectious Diseases Manhasset New York 11030-3816
University of Rochester Rochester New York 14642
SUNY Upstate Medical University Hospital - Pediatrics Syracuse New York 13210-2342
Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati Ohio 45229-3026
MetroHealth Medical Center - Pediatric Infectious Disease Cleveland Ohio 44109-1998
Children's Hospital of Philadelphia - The Center for Pediatric Clinical Effectiveness Philadelphia Pennsylvania 19104-3309
Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric Pittsburgh Pennsylvania 15213-3205
Rhode Island Hospital - Pediatrics Providence Rhode Island 02903-4923
Vanderbilt University - Pediatric - Infectious Diseases Nashville Tennessee 37232-0011
Parkland Memorial Hospital Dallas Texas 75235-7708
The University of Texas Southwestern Medical Center Dallas Texas 75390-9063
Cook Children's Infectious Disease Services Fort Worth Texas 76104-2710
University of Utah - Pediatric Pharmacology Program Salt Lake City Utah 84108-1457
Seattle Children's Hospital - Infectious Diseases Seattle Washington 98105-3901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00391768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00391768 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →